Skip to content

Zimmer Biomet Holdings (ZBH) Publicizes FDA Clearance of Persona OsseoTi Keel Tibia


Get instantaneous alerts when information breaks in your shares. Declare your 1-week free trial to Avenue Insider Premium right here.


Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a world medical know-how chief, as we speak introduced US Meals and Drug Administration (FDA) 510(okay) clearance for the Persona® OsseoTi® Keel Tibia for cementless knee substitute. Persona OsseoTi is the most recent addition to the clinically confirmed Persona Knee System, and encompasses a new porous model of the Persona anatomic tibia with Zimmer Biomet’s OsseoTi Porous Metallic Know-how, which makes use of anatomical knowledge together with 3D printing know-how to construct a construction that instantly mimics the structure of human cancellous-or spongey-bone. This materials is mixed with a keeled design to ship secure preliminary and organic fixation.

“With an rising variety of surgeons choosing cementless procedures for his or her sufferers, we’re excited to broaden our market-leading Persona Knee portfolio with the Persona OsseoTi Keel Tibia, a flexible and surgeon-centered answer for performing a cementless whole knee substitute,” stated Ivan Tornos, Chief Working Officer at Zimmer Biomet. “Including the Persona OsseoTi Keel Tibia to our well-established and clinically confirmed Persona Knee System permits surgeons to higher handle the wants of their sufferers with a complete single system answer for a cementless or cemented software. We’re proud to shut out the 12 months With one other development in our portfolio, because of the sturdy execution of our workforce members and our dedication to fueling development with innovation.”

Key options of Persona OsseoTi embody an anatomic tibia for much less micromotion and optimum bone protection and 3D printed, porous OsseoTi know-how for organic fixation. The Persona OsseoTi Keel Tibia can also be complemented with a brand new cemented implant choice to allow seamless versatility for the surgeon through the process.

“The expected development within the prevalence of arthritis in youthful, energetic sufferers has made cementless whole knee arthroplasty an more and more important possibility for surgeons,” stated Charles Lawrie, MD, orthopedic surgeon at Baptist Well being Orthopedic Care and Scientific Affiliate Professor on the Florida Worldwide College , Herbert Wertheim School of Drugs in Miami, FL, and a member of the Persona OsseoTi growth workforce. “Along with the spike-keel design, the Persona OsseoTi Keel Tibia affords the added comfort of a brand new cemented possibility with the identical bone prep because the cementless possibility in order that surgeons could make an intraoperative determination between a cementless or cemented strategy primarily based on bone high quality and the distinctive wants of their affected person.”

For extra details about the Persona OsseoTi Keel Tibia, go to https://www.zimmerbiomet.com/en/products-and-solutions/specialties/knee/persona-osseotikeeltibia.html.

About Zimmer Biomet

Zimmer Biomet is a world medical know-how chief with a complete portfolio designed to maximise mobility and enhance well being. We seamlessly remodel the affected person expertise by way of our revolutionary merchandise and suite of built-in digital and robotic applied sciences that leverage knowledge, knowledge analytics and synthetic intelligence.

With 90+ years of trusted management and confirmed experience, Zimmer Biomet is positioned to ship the very best high quality options to sufferers and suppliers. Our legacy continues to come back to life as we speak by way of our progressive tradition of evolution and innovation.

For extra details about our product portfolio, our operations in 25+ international locations and gross sales in 100+ international locations or about becoming a member of our workforce, go to www.zimmerbiomet.com or comply with Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

Cautionary Assertion Relating to Ahead-Trying Statements

This information launch incorporates forward-looking statements inside the that means of the protected harbor provisions of the Personal Securities Litigation Reform Act of 1995. Ahead-looking statements embody, however usually are not restricted to, statements regarding Zimmer Biomet’s expectations, plans, prospects, and product and repair choices, together with new product launches and potential scientific successes. Such statements are primarily based upon the present beliefs and expectations of administration and are topic to important dangers, uncertainties and modifications in circumstances that would trigger precise outcomes and outcomes to vary materially. For an inventory and outline of a few of such dangers and uncertainties, see Zimmer Biomet’s periodic experiences filed with the US Securities and Change Fee (SEC). These components shouldn’t be construed as exhaustive and needs to be learn along side the opposite precautionary statements which are included in Zimmer Biomet’s filings with the SEC. Ahead-looking statements communicate solely as of the date they’re made, and Zimmer Biomet disclaims any intention or obligation to replace or revise any forward-looking statements, whether or not because of new info, future occasions or in any other case. Readers of this information launch are cautioned to not depend on these forward-looking statements, since there could be no assurance that these forward-looking statements will show to be correct. This cautionary assertion is relevant to all forward-looking statements contained on this information launch.

i Knowledge on file with Zimmer Biomet: The Persona® OsseoTi® Keel Tibia Gives Robust Preliminary Fixation. Nov. 2022. 4027.1-GLBL-in

345 E. Major St. Warsaw, IN 46580www.zimmerbiomet.com

View unique content material to obtain media:https://www.prnewswire.com/news-releases/zimmer-biomet-expands-persona-knee-system-portfolio-with-fda-clearance-of-persona-osseoti-keel-tibia-for-cementless-knee- replacement-301683440.html

SOURCE Zimmer Biomet Holdings, Inc.

Leave a Reply

Your email address will not be published. Required fields are marked *